New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuropsychopharmacology

• Publication date

  1995-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0893-133X(95)00068-OPMID 8602893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET

  2005cited by this paper
• Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

  2005cited by this paper
• Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine

  2005cited by this paper
• Hippocampal benzodiazepine receptors in schizophrenia

  2005cited by this paper
• Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates

  2005cited by this paper
• Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

  2005cited by this paper
• Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats

  2005cited by this paper
• Prenatal developmental disturbances in the limbic allocortex in schizophrenics

  2005cited by this paper
• Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses?

  2005cited by this paper
• Multiple neurochemical action of clozapine: A quantitative autoradiographic study of DA 2, opiate and benzodiazepine receptors in the rat brain after long-term treatment

  2005cited by this paper
• Does treatment with haloperidol for 3 weeks produce depolarization block in midbrain dopamine neurons of unanaesthetized rats?

  2005cited by this paper
• Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

  2005cited by this paper
• Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2′-iodospiperone

  2005cited by this paper
• Human dopamine receptor subtypes—in vitro binding analysis using3H-SCH 23390 and3H-raclopride

  2005cited by this paper
• The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

  2005cited by this paper
• Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat

  2005cited by this paper
• Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age

  2004cited by this paper
• Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines

  2004cited by this paper
• Glutamate in schizophrenics and healthy controls

  2004cited by this paper
• Biochemical and behavioural properties of clozapine

  2004cited by this paper
• Synergistic blockade of some dopamine-mediated behaviours by (−)-sulpiride and SCH 23390 in the rat

  2004cited by this paper
• Quantitative cytoarchitectonics of the human cerebral cortex in schizophrenic dementia

  2004cited by this paper
• Clozapine — pharmacokinetic investigations and biochemical effects in man

  2004cited by this paper
• Basic biology of clozapine: electrophysiological and neuroendocrinological studies

  2004cited by this paper
• Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia

  2004cited by this paper
• Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection

  2004cited by this paper
• An early Phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients

  2004cited by this paper
• Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

  2004cited by this paper
• Single- vs Multiple-Dose Pharmacokinetics of Clozapine in Psychiatric Patients

  2004cited by this paper
• Clinical pharmacokinetics of clozapine in chronic schizophrenic patients

  2004cited by this paper
• Cell loss in the hippocampus of schizophrenics

  2004cited by this paper
• Dopamine in schizophrenia.

  1996cited by this paper
• Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.

  1994cited by this paper
• Elevated levels of clozapine in serum after addition of fluvoxamine.

  1994cited by this paper
• 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.

  1994cited by this paper
• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  1994cited by this paper
• Dopamine D4 receptors: curiouser and curiouser.

  1994cited by this paper
• Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.

  1994cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia

  1994cited by this paper
• Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.

  1994cited by this paper
• Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

  1993cited by this paper
• A Novel Rat Serotonin Receptor: Primary Structure, Pharmacology, and Expression Pattern in Distinct Brain Regions

  1993cited by this paper
• A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

  1993cited by this paper
• Further characterization of the effects of BMY 14802 on dopamine neuronal activity

  1993cited by this paper
• Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands.

  1993cited by this paper
• Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses?

  1993cited by this paper
• Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.

  1993cited by this paper
• A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

  1993cited by this paper
• Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.

  1993cited by this paper
• Tissue Concentrations of Clozapine and its Metabolites in the Rat

  1993cited by this paper
• A long‐term study of remoxipride in chronic schizophrenic patients

  1993cited by this paper
• Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.

  1993cited by this paper
• Haloperidol but Not Clozapine Increases Neurotensin Receptor mRNA Levels in Rat Substantia Nigra

  1993cited by this paper
• Dopamine D4 receptors elevated in schizophrenia

  1993cited by this paper
• Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.

  1993cited by this paper
• Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

  1993cited by this paper
• Computerised Tomography in Newly Diagnosed Schizophrenia and Schizophreniform Disorder

  1993cited by this paper
• Are neostriatal dopamine receptors co-localized?

  1993cited by this paper
• Neurobiology of schizophrenia.

  1993cited by this paper
• Dopamine receptors. The D4 and schizophrenia.

  1993cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper
• Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.

  1993cited by this paper
• Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands

  1993cited by this paper
• Entorhinal-hippocampal connections: a speculative view of their function.

  1993cited by this paper
• Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.

  1993cited by this paper
• Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.

  1993cited by this paper
• Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.

  1993cited by this paper
• Pharmacokinetics and Pharmacodynamics of Clozapine

  1993cited by this paper
• Pharmacological Effects of Zotepine and other Antipsychotics on the Central 5-HT2 Receptors

  1993cited by this paper
• Serotonin, dopamine and their interactions in schizophrenia

  1993cited by this paper
• Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.

  1993cited by this paper
• Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics

  1993cited by this paper
• The D4 and schizophrenia

  1993cited by this paper
• Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

  1993cited by this paper
• Signalling via rat dopamine D2-receptors expressed in mouse fibroblasts is not influenced by compounds binding to the sigma sites of these cells.

  1993cited by this paper
• Anti-glutamatergic effects of clozapine.

  1993cited by this paper
• Dopamine D4 receptor subtypes and response to clozapine.

  1993cited by this paper
• Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain.

  1992cited by this paper
• PET Analysis Indicates Atypical Central Dopamine Receptor Occupancy in Clozapine-Treated Patients

  1992cited by this paper
• Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs.

  1992cited by this paper
• Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue.

  1992cited by this paper
• Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

  1992cited by this paper
• Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.

  1992cited by this paper
• Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.

  1992cited by this paper
• Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats.

  1992cited by this paper
• Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells

  1992cited by this paper
• Acute effects of Sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons

  1992cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

  1992cited by this paper
• Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat.

  1992cited by this paper
• Clozapine-Associated Agranulocytosis: Risk and Aetiology

  1992cited by this paper
• Distribution of D5 dopamine receptor mRNA in rat brain.

  1992cited by this paper
• Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.

  1992cited by this paper
• The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.

  1992cited by this paper
• General Pharmacology of Clozapine

  1992cited by this paper
• Multiple dopamine D4 receptor variants in the human population

  1992cited by this paper
• Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.

  1992cited by this paper
• The current status of PET scanning with respect to schizophrenia.

  1992cited by this paper

• Negative symptomatology and clozapine-induced obsessive-compulsive symptoms: a cross-sectional analysis.

  2025cites this paper
• Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions

  2024cites this paper
• Informing individualized multi-scale neural signatures of clozapine response in patients with treatment-refractory schizophrenia

  2023cites this paper
• Chemogenetics of cell surface receptors: beyond genetic and pharmacological approaches

  2022cites this paper
• Chemogenetic Signaling in Space and Time: Considerations for Designing Neuroscience Experiments Using DREADDs

  2022cites this paper
• The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI

  2022cites this paper
• Evaluation of toxicity and teratogenicity of anti-psychotic drugs followed by determination of anti-psychotic property of Mangifera indica bark through behavioral assay on Danio rerio model

  2020cites this paper
• DISSECTING THE DETERMINANTS OF DECISIONS: SEX DIFFERENCES AND DISTRIBUTED REINFORCEMENT REVEALED IN A RAT CHOICE TASK

  2019cites this paper
• DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands

  2019cites this paper
• Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review.

  2019cites this paper
• Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes

  2018cites this paper
• Pimavanserin: novel pharmacotherapy for Parkinson’s disease psychosis

  2018cites this paper
• Functional Changes of Orexinergic Reaction to Psychoactive Substances

  2018cites this paper
• Body temperature regulation and drugs of abuse.

  2018cites this paper
• Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells

  2017cites this paper
• Priming locus coeruleus noradrenergic modulation of medial perforant path-dentate gyrus synaptic plasticity.

  2017cites this paper
• Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans

  2017cites this paper
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis

  2017cites this paper
• Discriminative stimulus properties of 1.25mg/kg clozapine in rats: Mediation by serotonin 5-HT2 and dopamine D4 receptors.

  2016cites this paper
• Possible natural therapeutics against schizophrenia and its acute and treatment resistant forms: a review

  2016cites this paper
• In Vivo Tissue Pharmacokinetics of Carbon-11-Labeled Clozapine in Healthy Volunteers: A Positron Emission Tomography Study

  2015cites this paper
• Genetische Polymorphismen im 5HT2A-Rezeptor und deren Einfluss auf das Erkrankungsrisiko und den Therapieverlauf bei Schizophrenie

  2014cites this paper
• Neuroleptic Drugs Affect Sympathetic and Thermogenic Reactions to Orexin A

  2014cites this paper
• Central α- and β-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks.

  2014cites this paper
• Management and prevention of agranulocytosis in patients receiving clozapine

  2013cites this paper
• Nicotine and clozapine cross‐prime the locus coeruleus noradrenergic system to induce long‐lasting potentiation in the rat hippocampus

  2013cites this paper
• Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.

  2013cites this paper
• Lack of association of the 5‐HT3A receptor with schizophrenia

  2012cites this paper
• Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?

  2012cites this paper
• Iloperidone, asenapine and lurasidone: a primer on their current status

  2012cites this paper
• Poster #13 RECEPTOR BINDING PROFILES OF ANTIPSYCHOTIC MEDICATIONS AND GLUCOSE DYSREGULATION: AN ACUTE ANIMAL MODEL

  2012cites this paper
• Neurobiological Background for the Development of New Drugs in Schizophrenia

  2011cites this paper
• Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.

  2011cites this paper
• Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.

  2011cites this paper
• ANTIPSYCHOTIC MEDICATION DURING PREGNANCY AND POSSIBLE BIRTH DEFECTS

  2011cites this paper
• The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

  2010cites this paper
• Kynurenic acid in psychiatric disorders : studies on the mechanisms of action

  2010cites this paper
• Review: The biological basis of antipsychotic response in schizophrenia

  2010cites this paper
• Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome.

  2009cites this paper
• Clozapine Interaction with Phosphatidyl Inositol 3-Kinase (PI3K)/Insulin Signaling Pathway in Caenorhabditis elegans

  2009cites this paper
• Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors

  2009cites this paper
• What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?

  2009cites this paper
• An immunocapture/scintillation proximity analysis of Gαq/11 activation by native serotonin (5‐HT)2A receptors in rat cortex: Blockade by clozapine and mirtazapine

  2008cites this paper
• Differential regional and dose-related effects of asenapine on dopamine receptor subtypes

  2008cites this paper
• Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration

  2008cites this paper
• The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine.

  2008cites this paper
• Antipsychotic Medication Utilization Trends Among Texas Veterans: 1997–2002

  2008cites this paper
• Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.

  2008cites this paper
• The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats.

  2008cites this paper
• Clozapine and olanzapine but not risperidone impair the pre-frontal striatal system in relation to egocentric spatial orientation in a Y-maze.

  2007cites this paper
• Neurotransmitter receptor binding in the posterior cingulate cortex in schizophrenia and in the phencyclidine mouse model: an exploration of the NMDA hypofunction hypothesis of schizophrenia

  2007cites this paper
• Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.

  2007cites this paper
• Hirnelektrische Hypofrontalität bei schizophrenen Patienten und ihre Bedeutung für die Auswahl der neuroleptischen Medikation

  2007cites this paper
• Lipogenic effects of antipsychotic drugs in cultured cells and in rat

  2007cites this paper
• Finding Genes Underlying Schizophrenia Retinoid and Thyroid Hormone Hypotheses

  2007cites this paper
• Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.

  2007cites this paper
• Selective blockade of dopamine D3 versus D2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

  2007cites this paper
• In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.

  2006cites this paper
• Antipsychotic drug utilization patterns and treatment -emergent diabetes: A methodological comparison of incidence using a claims database

  2006cites this paper
• Endogenous kynurenic acid and schizophrenia : Physiological and pharmacological aspects

  2006cites this paper
• Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.

  2006cites this paper
• Long‐term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes

  2006cites this paper
• Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.

  2006cites this paper
• Differently lasting effects of prenatal and postnatal chronic clozapine/haloperidol on activity and memory in mouse offspring.

  2006cites this paper
• Antipsychotic-Like vs Cataleptogenic Actions in Mice of Novel Antipsychotics Having D2 Antagonist and 5-HT1A Agonist Properties

  2006influential citation
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• The effect of Ondansetron on memory in schizophrenic patients.

  2005cites this paper
• Socioeconomic status of origin and the clinical expression of Schizophrenia.

  2005cites this paper
• Alterations in the behaviour and level of neurotransmitters after acute and repeated administration of the psychostimulant plant , Catha edulis and its active principle , cathinone in rats

  2005cites this paper
• Prévalence et caractéristiques de l'association de neuroleptiques chez une cohorte de patients psychotiques

  2005cites this paper
• SCHIZOPHRENIA: FROM NEUROSCIENCE TO CLINICAL EXPERIENCE

  2005cites this paper
• Glutamatergic mechanisms in schizophrenia : Role of endogenous kynurenic acid

  2005cites this paper
• 2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes.

  2005cites this paper
• Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.

  2005cites this paper
• Blood biogenic amines during clozapine treatment of early-onset schizophrenia

  2005cites this paper
• The search for novel antipsychotics: pharmacological and molecular targets

  2004cites this paper
• Focus on polypharmacy in schizophrenia: does anyone truly benefit?

  2004cites this paper
• Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine

  2004cites this paper
• Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?

  2004cites this paper
• Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.

  2004cites this paper
• Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine.

  2004cites this paper
• Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.

  2004cites this paper
• Duloxetine's role in the treatment of depression and associated painful physical symptoms.

  2004cites this paper
• Modulation des neurones GABAergiques du mésencéphale ventral

  2004cites this paper
• Dopamine D4 Receptors: Beyond Schizophrenia

  2004cites this paper
• Schizophrenia and binge-eating disorders.

  2004cites this paper
• Clozapine blocks sympathetic and thermogenic reactions induced by orexin A in rat.

  2004cites this paper
• Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: A family based association study

  2004cites this paper
• Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization.

  2004cites this paper
• α-Thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

  2004cites this paper
• Clozapine reduces alcohol drinking in Syrian golden hamsters.

  2004cites this paper
• Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

  2004influential citation
• Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia.

  2003cites this paper
• Glutamatergic mechanisms in schizophrenia.

  2003cites this paper
• The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+‐induced apoptosis

  2003cites this paper
• Schizophrenia: from phenomenology to neurobiology

  2003influential citation
• Disruption and Potentiation of Latent Inhibition by Risperidone: The Latent Inhibition Model of Atypical Antipsychotic Action

  2003cites this paper
• Inhibitory Action of Clozapine on Rat Ventral Tegmental Area Dopamine Neurons Following Increased Levels of Endogenous Kynurenic Acid

  2003cites this paper
• Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.

  2003cites this paper
• Opposite regulation by typical and atypical anti‐psychotics of ERK1/2, CREB and Elk‐1 phosphorylation in mouse dorsal striatum

  2003cites this paper